Holen Sie sich die Stockscreener-App
7.11
1.11%
-0.08
Handel nachbörslich:
7.11
Schlusskurs vom Vortag:
$7.19
Offen:
$7.18
24-Stunden-Volumen:
96,925
Relative Volume:
0.59
Marktkapitalisierung:
$266.18M
Einnahmen:
$128.45M
Nettoeinkommen (Verlust:
$6.54M
KGV:
142.20
EPS:
0.05
Netto-Cashflow:
$-8.79M
1W Leistung:
+5.65%
1M Leistung:
+1.86%
6M Leistung:
-2.47%
1J Leistung:
+21.02%
1-Tages-Spanne:
$7.02
$7.208
1-Wochen-Bereich:
$6.61
$7.37
52-Wochen-Spanne:
$4.76
$8.85
Lifecore Biomedical Inc Stock (LFCR) Company Profile
Firmenname
Lifecore Biomedical Inc
Sektor
Telefon
(952) 368-4300
Adresse
3515 LYMAN BOULEVARD, CHASKA
Vergleichen Sie LFCR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LFCR
Lifecore Biomedical Inc
|
7.11 | 269.38M | 128.45M | 6.54M | -8.79M | 0.05 |
|
ZTS
Zoetis Inc
|
144.35 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.42 | 42.46B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.38 | 41.28B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.52 | 23.49B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
438.66 | 19.18B | 3.08B | 1.24B | 1.07B | 25.61 |
Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-04 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2025-05-21 | Eingeleitet | William Blair | Outperform |
| 2024-09-05 | Eingeleitet | Craig Hallum | Buy |
| 2024-08-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2023-03-20 | Herabstufung | Stephens | Overweight → Equal-Weight |
Lifecore Biomedical Inc Aktie (LFCR) Neueste Nachrichten
Lifecore Selected as Commercial Mfg. Partner for Leading Injectable Product - Contract Pharma
What candlestick patterns are forming on Lifecore Biomedical Inc.Bear Alert & Weekly High Potential Stock Alerts - newser.com
Market reaction to Lifecore Biomedical Inc.’s recent newsMarket Risk Summary & Daily Market Momentum Tracking - newser.com
Is Lifecore Biomedical Inc. stock ready for breakoutPortfolio Growth Summary & Advanced Swing Trade Entry Alerts - newser.com
Will Lifecore Biomedical Inc. outperform the marketWeekly Market Outlook & Free Real-Time Volume Trigger Notifications - newser.com
Should I hold or sell Lifecore Biomedical Inc. stock in 2025Weekly Investment Summary & Expert Approved Trade Ideas - newser.com
How Lifecore Biomedical Inc. stock benefits from strong dollarAnalyst Downgrade & Daily Volume Surge Signals - newser.com
Will Lifecore Biomedical Inc. (LDE) stock recover faster than industryTrade Ideas & Expert Curated Trade Ideas - newser.com
What catalysts could drive Lifecore Biomedical Inc. stock higher2025 AllTime Highs & Safe Capital Growth Trade Ideas - newser.com
Is it too late to sell Lifecore Biomedical Inc.July 2025 EndofMonth & Reliable Volume Spike Alerts - newser.com
Can Lifecore Biomedical Inc. stock weather global recessionCPI Data & Advanced Technical Analysis Signals - newser.com
Is Lifecore Biomedical Inc. forming a reversal patternSell Signal & Safe Entry Point Identification - newser.com
Can Lifecore Biomedical Inc. stock beat market expectations this quarterJuly 2025 Breakouts & Free Reliable Trade Execution Plans - newser.com
Real time pattern detection on Lifecore Biomedical Inc. stockRate Cut & Long-Term Capital Growth Strategies - newser.com
Is Lifecore Biomedical Inc. stock affected by interest rate hikes2025 Investor Takeaways & Smart Money Movement Tracker - newser.com
What hedge fund moves indicate for Lifecore Biomedical Inc. (LDE) stock2025 AllTime Highs & Daily Profit Focused Screening - newser.com
When is the best time to exit Lifecore Biomedical Inc.July 2025 Rallies & Low Drawdown Investment Strategies - newser.com
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Is Lifecore Biomedical Inc. (LDE) stock undervalued after correctionJuly 2025 Opening Moves & Weekly High Return Stock Forecasts - newser.com
Key metrics from Lifecore Biomedical Inc.’s quarterly dataMarket Activity Summary & Daily Technical Stock Forecast Reports - newser.com
Why pension funds invest in Lifecore Biomedical Inc. (LDE) stockMarket Activity Recap & Precise Buy Zone Tips - newser.com
Why millennials buy Lifecore Biomedical Inc. (LDE) stock2025 Sector Review & Safe Investment Capital Preservation Plans - newser.com
Will Lifecore Biomedical Inc. (LDE) stock see insider accumulation2025 Support & Resistance & Real-Time Stock Movement Alerts - newser.com
Lifecore Biomedical earnings beat, revenue fell short of estimates By Investing.com - Investing.com Canada
Lifecore Biomedical Approves Key Proposals at Annual Meeting - TipRanks
LFCR 2025 meeting: board elected, KPMG ratified, say-on-pay OK - Stock Titan
Is Lifecore Biomedical Inc. (LDE) stock suitable for passive index fundsJuly 2025 Selloffs & Technical Entry and Exit Alerts - newser.com
Will Lifecore Biomedical Inc. (LDE) stock gain from lower interest ratesJuly 2025 Momentum & Daily Profit Focused Screening - newser.com
Lifecore Biomedical to Report Financial Results for the Three Months Ended September 30, 2025, on November 6, 2025 - The Manila Times
Lifecore, PolyPeptide collab to offer peptide manufacturing solution - MSN
Finanzdaten der Lifecore Biomedical Inc-Aktie (LFCR)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.35%
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):